Phoenix
  • About
  • Team
  • Strategic Partners
  • Advisors
  • Companies
  • Testimonials
  • News
  • Incubators
  • LP Portal
  • Contact
  • Facebook
  • Linkedin
Select Page
ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development.

ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development.

Apr 16, 2018 | News, Press Release

Collaboration will provide clients competitive advantages, improve speed to market. KBI makes equity investment in ReForm Biologics along with existing investors. CAMBRIDGE, Mass. and Durham, NC – April 4, 2018 – ReForm Biologics and KBI Biopharma, Inc., (KBI) today...

Recent Posts

  • ReForm Biologics Announces Issuance of U.S. Patent on Additional Excipients for Therapeutic Protein Formulations
  • Former Panasonic North America CEO and New VP Boost Imprint Energy Business Team
  • Imprint Energy Expands Access to Safe, Flexible Batteries for High-Volume IoT Applications
  • ReForm Biologics Announces Two New Technology Presentations at Bioprocessing Summit 2019
  • ReForm Biologics inks evaluation deal with Bayer

Archives

  • ►2019
    • November
    • August
    • May
    • April
    • March
    • January
  • ►2018
    • October
    • September
    • August
    • July
    • May
    • April
    • March
    • February
  • ►2017
    • December
    • November
    • October
    • July
    • June
    • May
    • March
    • February
    • January
  • ►2016
    • October
    • September
    • August
    • May
    • April
  • ►2015
    • October
    • August
  • ►2013
    • September
  • ►2012
    • October
    • April
    • March
    • February
    • January

Categories

  • Article
  • Interview
  • News
  • Press Release
  • Show All
Please note that use of this website is subject to your acceptance of the TERMS AND CONDITIONS OF USE AND PRIVACY POLICY. I am not a resident of the European Union.OkNoPrivacy Policy